Story: First Case of Adipose Derived Stem Cells for Repairing Human Skull Defects Reported
Story: Gene Therapy Cures Boys of Severe Combined Immunodeficiency
MIT Researchers Grow Heart Tissue from Rats’ Cells
How Human Blood Stem Cells Transform Themselves to Repair Injured Animal Hearts
Stem Cells ‘To Treat Liver Harm’
Stem Cell Transplants Help Mice See
New Stem-cell Sources May End Ethics Debate
BBC Rekindles Adult vs. Embryo Stem Cell Cloning Debate
Ethicists Wary of New Stem Cell Proposals
“Nano-needle” Operates on Cell: Could Be Used to Manipulate Embryonic Stem Cells Intended For Use In Medical Treatment
“Nano-scissors” Laser Shows Precise Surgical Capability
Eph Affects T Cell Function
Injectable Gel That Holds Cartilage-Producing Cells in Place Could Speed Repair of Torn Cartilage
New Model of Rare Childhood Blindness Holds Promise for Testing Preventive Gene Therapies
Novel p53 Gene-Based Therapy Boosts Immune System and Reduces Tumor Size
Gene Vaccine For Alzheimer’s Disease Shows Promising Results
Small Variations in Genes Can Determine Risk of Developing Breast Cancer
Study IDs Key Aspect Of Immune Response Against HIV
Israeli-developed Leukemia Treatment Passes Clinical Hurdle
TRALI Consensus Recommendations Published in AABB’s Transfusion Journal
Canadian Blood Services Launches transfusionmedicine.ca
ABSTRACTS, REVIEWS, & SPECIAL REPORTS
Comparison of High-capacity and First-generation Adenoviral Vector Gene Delivery to Murine Muscle In Utero
Isolation of Cancer Stem Cells from Adult Glioblastoma Multiforme
Life-threatening Neurological Complications After Bone Marrow Transplantation in Children
Sonic Hedgehog Gene-enhanced Tissue Engineering for Bone Regeneration
Schwarzenegger Nominates Stem Cell Research Chief
Illinois Stem cell Tax Vote Expected in Spring
Minnesota Funding Proposed for Stem Cell Research
Stem Cell Committee at 22; Five More to Go
StemCell Technologies to Distribute AllCells’ Product Line Worldwide
Chromos Enters into Agreement with Pfizer to Develop Cell Lines for Production of Recombinant Proteins
Amgen Names Willard Dere Senior Vice President, Global Development
FDA Approves Amgen’s Kepivance for Severe Oral Mucositis in Cancer Patients Undergoing Bone Marrow Transplant
CytoGenix Inc. Invents Revolutionary Large-Scale Manufacturing Process for High-Purity DNA
Dendreon’s APC8024 Immunotherapy Shows Promise in Advanced Breast Cancer
Genmab’s HuMax-CD20 to Treat CLL Awarded Fast Track Status from FDA
Genzyme Announces Gene Therapy Collaboration with Applied Genetic Technologies
MediBIC and DNA 2.0 Enter R&D Agreement for Protein Engineering and Gene Synthesis Distribution in Japan
Malachite Management has joined forces with established and reputable authors and publishers to bring you the following market reports outlining the very latest in Cell Therapy, Gene Therapy and Immunotherapeutic Approaches to Cancer.
“Cell Therapy – Technologies, Markets, and Companies” is over 400 pages of the basic technologies, clinical applications, market analysis, and company profiles related to the cell therapy industry worldwide.For more information and to order see:
Cell Therapy Report Summary
Cell Therapy Sample Chapter
Cell Therapy Table of Contents
Cell Therapy Order Form
“Gene Therapy – Technologies, Markets and Companies” is 560 pages of the basic technologies, clinical applications, market analysis, and company profiles related to the gene therapy industry worldwide.
For more information and to order see:
Gene Therapy Report Summary
Gene Therapy Table of Contents Vol. 1 Vol. 2
Gene Therapy Order Form
The Immunotherapy Reports cover the most recent developments in the immunotherapeutic approaches to cancer.
A Shift in Cancer Immunotherapy Stategies?
Immunotherapy Strategies Executive Summary
Immunotherapy Strategies Table of Contents
Future Perspectives in Cancer Immunotherapy
Future Perspectives Executive Summary
Future Perspectives Table of Contents
Immunotherapy Reports Order Form
New Contract Allows NIGMS Cell Repository to Continue Providing Key Genetic Research ResourcesArticle
All new CBER information can be reached from the What’s New page
Potential Hemolysis in Red Blood Cells and Whole Blood Leukocyte Reduced Products Manufactured with the Pall BPF4 Filter
(Update) Posted: 12/17/2004, Notification Date: 12/17/2004
Recall of Leukocyte Reduction BPF4 High Efficiency Filter (Pall Medical
Corp) Posted: 12/17/2004, Recall Date: 12/17/2004
Potential Hemolysis in Red Blood Cells and Whole Blood Leukocyte Reduced Products Manufactured with the Pall BPF4 FilterPosted: 12/11/2004, Notification Date: 12/10/2004
Cleared Biologics 510(k) Device Applications – Update
Posted: 12/6/2004, Updated through: 11/30/2004
2004 Biological Approvals – Update
Posted: 12/9/2004, Updated through: 11/30/2004
FDA/DIA Scientific Workshop on Follow-on Protein Pharmaceuticals
Posted: 12/17/2004, Workshop Date: 2/14-16/2005
Advisory Committee Meetings – 2005 Schedule
For Country-Specific & International Regulatory Resources, Including Links to Regulatory Agencies Such as the FDA, EMEA, & More Click Here
NEWS & UPDATES
FDA’s Official Terms, Lists and Training Rules Now at Your Fingertips with this 3-Book Set
FDA’s Medical Devices Premarket Approval Applications, List; Safety and Effectiveness Summaries Availability
The National Health and Medical Research Council (NHMRC) Bans Human Clinical Trials of Animal Cellular Therapies for Five Years
EMEA Issues Guildine, Concept Papers on Generic Biologics Including Erythropoietin, Human Growth Hormone, Granulocyte-colony Stimulating Factor and Insulin
MALACHITE’S ONLINE CONFERENCE CALENDAR
For a more complete listing of conferences, see Malachite Management’s new online, interactive
Cell Therapy Calendar
cGMP in the Transfusion Service. An online training course.
NIH and other Stem Cell Training Courses
Weekly – UCSFs Human Embryonic Stem Cell Training Program (3-day training course).
Free CME Program: Prophylaxis & Pre-emptive Therapy in Patients at Risk for CMV Infection After Stem Cell Transplant
This activity has been designated to meet the educational needs of physicians involved in the management of patients undergoing stem cell transplantation
Jan. 5 Complete Quality Competency.(Part of the Cellular Therapy Audioconference Series)
Jan. 10-13 CHI’s PepTalk Conference: The Protein Information Week. San Diego, California
Jan. 17-28, BMRC-EMBO Practical Course on Advanced Optical Methods in Cell and Developmental Biology. Biopolis, Singapore
Application deadline: Nov. 15, 2004 (Selected Participants pay only travel costs)
Jan. 20-22 Stem Cell Transplantation in Children: Current Results and Controversies. Scottsdale, Arizona
Jan. 24-26 Phacilitate Cell & Gene Therapy Forum. Washington DC
Jan 26 Complications of Blood Donations. (Part of the Cellular Therapy Audioconference Series)
Jan. 24 Overview of Staged Implementation of GMP During Biological/Biotechnological Product Development. Alexandria, VA
Jan. 25 Current Best Practices in Purification Development & Validation. Alexandria, VA
Jan. 26 Best Practices in Analytical Test Method Validation. Alexandria, VA
Jan. 27 Best Practices in Commissioning cGMP Laboratory Equipment. Alexandria, VA
Jan 27-28 Cytokines & Inflammation. San Francisco, California
Jan.28 Operational Factors for Improved Laboratory Quality and Compliance. Alexandria, VA
Jan. 31 Establishing Realistic Process and Test Method Specifications. Alexandria, VAFEBRUARY
Feb 1-3 FDA and the New Paradigm for Tissue Regulation Conference. Dallas, Texas
Feb. 1-4 International Congress on Anti-Cancer Treatment. Paris, France
Feb. 2 Transfusion Service and Blood Center Cooperation in the Management of Serious Transfusion Reactions. (Part of the Cellular Therapy Audioconference Series)
Feb. 3 Key Issues in Formulation Development for Biotechnology Products. Alexandria, VA
Feb. 4 Auditing In-House and Contract Labs for CMC Development Studies and GLP/GMP Compliance. Alexandria, VA
Feb.10-15 Molecular Regulation of Stem Cells. Banff, Alberta
Feb. 10-14 Tandem BMT Meetings (Combined ASBMT and IBMTR/ABMTR annual meetings). Keystone, Colo.
Feb. 16 Basic Antibody Identification. (Part of the Cellular Therapy Audioconference Series)
Feb. 23-25: The Clinical Trials Congress – Philadelphia
Feb. 23 Process Validation/Qualification for Cell Therapy Procedures. ( Part of the Cellular Therapy Audioconference).
Mar. 2 Introducing the 23rd Edition of Standards for Blood Banks and Transfusion Services. ( Part of the Cellular Therapy Audioconference).
Mar 3-4 Commercialisation of Stem Cells: Are Stem Cells Commercially Viable? London, UK
Mar. 4-5 Stem Cell 2005: Progress to Therapy? EICC, Edinburgh, Scotland
Mar. 16 Advanced Transfusion Reactions. ( Part of the Cellular Therapy Audioconference).
Mar. 17-18 3rd International Symposium on Cellular Therapy. Regensburg, Germany
Mar. 16-20 American Society of Transplantation (AST) and Canadian Society of Transplantation (CST) Annual Winter Symposium. Banff, Canada.
Mar. 20–23 European Group for Blood & Marrow Transplantation Annual Mtg. Prague, Czech Republic.
Mar. 30 Cord Blood Banking and Transplantation: Decision Making for Selection of Cord Blood Units.( Part of the Cellular Therapy Audioconference).
Apr. 6 Team Approach to Red Blood Cell Exchange.( Part of the Cellular Therapy Audioconference).
Apr. 11-12 Stem Cells Research & Therapeutics. San Diego, California
Apr. 11-13 R&D Leaders’ Forum Spring 2005. The Biltmore Hotel, Coral Gables, FL
Apr. 13 Reimbursement Guide for Blood Products and Services. ( Part of the Cellular Therapy Audioconference).
Apr. 20 Biology of Stem Cell Mobilization. ( Part of the Cellular Therapy Audioconference).
Apr. 27-30 American Society for Apheresis 26th Annual Meeting Chicago, IL.
May 3-4, Current Good Tissue Practice. Vancouver, BC
Workshop Chairs: Janice Davis-Sproul, MAS, MT (ASCP) SBB (John Hopkins Univeristy) & John McMannis, PhD (MD Anderson Cancer Center)
May 3-7. 11th Annual Meeting and Scientific Conference of the International Society for Cellular Therapy (ISCT) Vancouver, Canada. (combined with Good Tissue Practices Workshop & Flow Cytometry for HSC Transplantation Workshop)
May 4 West Nile Virus and SARS: Challenges to Transfusion Safety, Then and Now. ( Part of the Cellular Therapy Audioconference).
May 4-7th, Applications of Flow Cytometry in Marrow and Stem Cell Transplantation. Vancouver, BC
May 11 Increasing Collections: Three Successful Case Studies ( Part of the Cellular Therapy Audioconference).
May 11-14 International Symposium on Technological Innovations in Laboratory Hematology (ISLH). San Francisco, California, USA
May 12-16 5th Annual Conference of the Federation of Clinical Immunology Societies (FOCIS). Boston, Massachusetts
May 14-16 American Society of Pediatric Hematology/Oncology (ASPH/O) 18th Annual Meeting. Washington, D.C.
May 14-17 American Society of Clinical Oncology (ASCO). Orlando, FL, USA
May 18 Leadership and Self-Deception ( Part of the Cellular Therapy Audioconference).
May 18-20 2nd World Congress on Regenerative Medicine. Leipzig, Germany.
May 20-25 American Society of Transplantation (AST) American Transplant Congress. Seattle, Washington
May 23-25 Phacilitate Vaccine Forum Spring 2005.Amsterdam
June 1 Facility Requirements for a Cell Therapy Laboratory ( Part of the Cellular Therapy Audioconference).
June 1-5 American Society of Gene Therapy Annual Meeting. Saint Louis, MO.
June 2-5 European Hematology Association Meeting. Stockholm, Sweden
June 3-4 3rd Annual International Umbilical Cord Blood Transplant Symposium.Los Angeles, California
June 5 Serological Case Studies: They Didn’t Tell Me about This in School.( Part of the Cellular Therapy Audioconference).
June 22 Two Sides of the Same Coin: Getting the Most from External Assessments.( Part of the Cellular Therapy Audioconference).
June 23-25 3rd Annual Meeting of the International Society for Stem Cell Research. San Francisco, CA.
July 13 Unrelated Donor Hematopoietic Cell Transplantation: The Effect of Hematopoietic Cell Source, Cell Dose and Conditioning Regimen on Recipient Outcome. ( Part of the Cellular Therapy Audioconference).
July 20 Therapeutic Apheresis in Practice: What’s New? ( Part of the Cellular Therapy Audioconference).
July 27 My Ideal Donor Center. ( Part of the Cellular Therapy Audioconference).
Jul.30- Aug 2 International Society for Experimental Hematology Tradition Meets Innovation 34th Annual Scientific Meeting.Glasgow, Scotland
Aug. 10 Creative Training Techniques: Stepping Out of the Training Box.( Part of the Cellular Therapy Audioconference).
Sept. 14 Hematopoietic Progenitor Cell Transplantation: Transfusion Requirements and Immunohematologic Complications. ( Part of the Cellular Therapy Audioconference).
Sept. 21 Changes in the New AABB Technical Manual. ( Part of the Cellular Therapy Audioconference).
Sept. 21-25 International Society of Pediatric Oncology Conference. Vancouver, Canada.
Sept/Oct Second International Epithelial Mesenchymal Transfer Conference. Vancouver, Canada.
To View a List of Cell Therapy-Related Journals Click Here
JOB POSTINGS IN CELL THERAPY NEWS ARE FREE!
For information on posting an opportunity email: tiffany
Business Development Associate NEW!
Vancouver, BC (StemCell Technologies)
Buyer / Purchaser
Vancouver, BC (StemCell Technologies)
Cell Therapy Laboratory Positions
Houston, Texas (MD Anderson Cancer Center)
Cellular Therapy Laboratory Manager
Seattle, Washington (Seattle Cancer Alliance Center)
Chief Medical Scientist
Dublin, Ireland (St. James Hospital)
Bethesda, MD (CBER)
Clinical Laboratory Scientist- Cellular Therapies Laboratory
Cincinnati, Ohio (Hoxworth Blood Center)
Consumer Safety Officer (Biological Drug & Device Compliance Branch) NEW!
Rockville, MD. (CBER)
Director of Cellular Therapies
Baltimore, Maryland (AABB)
Director of Oncology/Hematology Medical Communications
New Jersey (Confidential)
Manager, Regulatory Affairs- Transplant Production Facility
Omaha, Nebraska (The Nebraska Medical Center)
Medical Technologist- Stem Cell Lab
Salt Lake City, Utah (University of Utah)
Dublin Ireland (St. James Hospital)
Regulatory Information Specialist (Office of Biostatistics and Epidemiology) NEW!
Montgomery County, MD (CBER)
Regulatory Information Specialist (Division of Viral Products) NEW!
Montgomery County, MD (CBER)
Section Chief Technologists-Stem Cell
Amman, Jordan (King Hussein Cancer Center)
Senior Scientist, Process Development: TVAX Product
Menlo Park, California (Geron)
International Society for Cellular Therapy
ISCT’s Quality Assurance Group launches online discussion board to discuss Quality Management issues via open, honest discussion by experienced, interested parties.
Upcoming Meetings & Conferences:
2003-4 Cell Therapy Audioconference Series
May 3-4, 2005 Current Good Tissue Practice. Vancouver, BC
Workshop Chairs: Janice Davis-Sproul, MAS, MT (ASCP) SBB (John Hopkins University) & John McMannis, PhD (MD Anderson Cancer Center)
May 4-7th, 2005 11th Annual ISCT Meeting. Vancouver, BC
Program Themes Include: Tissue Engineering, Mesenchymal Stem Cells, Immunotherapy, & Hematopoietic Stem Cells
May 4-7th, 2005 Applications of Flow Cytometry in Marrow and Stem Cell Transplantation. Vancouver, BC
Interested in Advertising in Cytotherapy?
For more information and advertising rates, Click here
Read Cytotherapy in 2005! Join ISCT ($130) and receive the journal as a benefit of membership
The Current Issue is: Volume 6, Number 5 / October 2004
Cytotherapy publishes original research, reviews, meeting reports, special focus issues and letters in the general field of cell therapy. The scope of the journal includes includes basic and applied research with hematopoietic and non-hematopoietic stem cells , immune cells, and antigen-presenting cells. Therapeutic topics within the scope of Cytotherapy include ex-vivo and in-vivo aspects of gene therapy, immunotherapy, stem cell transplantation and tissue regeneration. Cytotherapy particularly welcomes
contributions from researchers, clinicians, technicians and individuals involved in regulatory aspects of cell therapy.